Also known as آسٹیوپوروسس مینجمنٹ
Infectious Disease Specialist
M.B.B.S., F.C.P.S., F.C.P.S.
Diabetologist
M.B.B.S, P.G Diabetes, M.Sc Diabetes
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Internal Medicine Specialist
M.B.B.S, M.R.C.P
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Internal Medicine Specialist
MBBS, MD (Internal Medicine), MRCP
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, M.R.C.P (Medicine), MRCGP (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures